A. Hay

994 total citations
9 papers, 693 citations indexed

About

A. Hay is a scholar working on Reproductive Medicine, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, A. Hay has authored 9 papers receiving a total of 693 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Reproductive Medicine, 5 papers in Surgery and 3 papers in Pathology and Forensic Medicine. Recurrent topics in A. Hay's work include Ovarian cancer diagnosis and treatment (9 papers), Intraperitoneal and Appendiceal Malignancies (5 papers) and Cancer, Lipids, and Metabolism (2 papers). A. Hay is often cited by papers focused on Ovarian cancer diagnosis and treatment (9 papers), Intraperitoneal and Appendiceal Malignancies (5 papers) and Cancer, Lipids, and Metabolism (2 papers). A. Hay collaborates with scholars based in United Kingdom, Australia and United States. A. Hay's co-authors include P. Vasey, Stuart Kaye, David E. Parkin, R. Atkinson, Amanda Gordon, Gordon C. Jayson, Hani Gabra, J. P. Paul, Robert L. Coleman and James Paul and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Annals of Oncology.

In The Last Decade

A. Hay

9 papers receiving 675 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Hay United Kingdom 6 505 302 274 207 99 9 693
M F Brady United States 5 491 1.0× 236 0.8× 184 0.7× 170 0.8× 91 0.9× 8 600
María Jesús Rubio Spain 16 506 1.0× 344 1.1× 180 0.7× 214 1.0× 76 0.8× 48 693
S. Olbricht Germany 9 727 1.4× 414 1.4× 327 1.2× 280 1.4× 86 0.9× 14 887
Ulrich Canzler Germany 13 528 1.0× 303 1.0× 226 0.8× 196 0.9× 85 0.9× 48 683
Delaloye Jf Switzerland 3 735 1.5× 422 1.4× 346 1.3× 281 1.4× 114 1.2× 8 935
Fumitoshi Terauchi Japan 10 511 1.0× 186 0.6× 211 0.8× 262 1.3× 142 1.4× 31 716
M. A. Bookman United States 9 316 0.6× 217 0.7× 237 0.9× 111 0.5× 102 1.0× 15 583
G. P. Breitbach Germany 10 413 0.8× 330 1.1× 222 0.8× 239 1.2× 33 0.3× 36 685
H D Homesley United States 9 468 0.9× 335 1.1× 163 0.6× 218 1.1× 58 0.6× 12 611
Stacy Nerenstone United States 7 281 0.6× 237 0.8× 122 0.4× 188 0.9× 74 0.7× 9 589

Countries citing papers authored by A. Hay

Since Specialization
Citations

This map shows the geographic impact of A. Hay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Hay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Hay more than expected).

Fields of papers citing papers by A. Hay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Hay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Hay. The network helps show where A. Hay may publish in the future.

Co-authorship network of co-authors of A. Hay

This figure shows the co-authorship network connecting the top 25 collaborators of A. Hay. A scholar is included among the top collaborators of A. Hay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Hay. A. Hay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Barrett, Sophie, James Paul, A. Hay, et al.. (2008). Does body mass index affect progression-free or overall survival in patients with ovarian cancer? Results from SCOTROC I trial. Annals of Oncology. 19(5). 898–902. 69 indexed citations
2.
Paul, James, et al.. (2006). In Reply:. Journal of Clinical Oncology. 24(15). 2396–2397. 4 indexed citations
3.
Paul, James, et al.. (2006). In Reply:. Journal of Clinical Oncology. 24(15). 2398–2399. 1 indexed citations
4.
Reed, Nicholas, Robert E. Coleman, David E. Parkin, et al.. (2005). A randomised comparison of treosulfan and carboplatin in patients with ovarian cancer: A study by the Scottish Gynaecological Cancer Trials Group (SGCTG). European Journal of Cancer. 42(2). 179–185. 12 indexed citations
5.
Vasey, P., et al.. (2005). Does aggressive surgery only benefit patients with less advanced ovarian cancer? Results from an international comparison within the SCOTROC-1 trial. Journal of Clinical Oncology. 23(16_suppl). 5003–5003. 12 indexed citations
6.
Vasey, P., et al.. (2005). Does Aggressive Surgery Only Benefit Patients With Less Advanced Ovarian Cancer? Results From an International Comparison Within the SCOTROC-1 Trial. Journal of Clinical Oncology. 23(34). 8802–8811. 139 indexed citations
7.
Vasey, P., Gordon C. Jayson, Amanda Gordon, et al.. (2004). Phase III Randomized Trial of Docetaxel-Carboplatin Versus Paclitaxel-Carboplatin as First-line Chemotherapy for Ovarian Carcinoma. JNCI Journal of the National Cancer Institute. 96(22). 1682–1691. 446 indexed citations
8.
Crawford, S. M., James Paul, N.S. Reed, et al.. (2004). The prognostic significance of the CA125 nadir in patients that achieve a CA125 response. Journal of Clinical Oncology. 22(14_suppl). 5001–5001. 6 indexed citations
9.
Crawford, S. M., James Paul, N.S. Reed, et al.. (2004). The prognostic significance of the CA125 nadir in patients that achieve a CA125 response. Journal of Clinical Oncology. 22(14_suppl). 5001–5001. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026